These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of propafenone on the pharmacokinetics of digoxin administered orally: a study in healthy volunteers]. Cardaioli P; Compostella L; De Domenico R; Papalia D; Zeppellini R; Libardoni M; Pulido E; Cucchini F G Ital Cardiol; 1986 Mar; 16(3):237-40. PubMed ID: 3732716 [TBL] [Abstract][Full Text] [Related]
3. Quinidine-digoxin interaction: cardiac efficacy of elevated serum digoxin concentration. Belz GG; Doering W; Aust PE; Heinz M; Matthews J; Schneider B Clin Pharmacol Ther; 1982 May; 31(5):548-54. PubMed ID: 7075104 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interactions between digoxin and other drugs. Marcus FI J Am Coll Cardiol; 1985 May; 5(5 Suppl A):82A-90A. PubMed ID: 2985676 [TBL] [Abstract][Full Text] [Related]
6. [The interaction of antiarrhythmic drugs with other drugs]. Yamaguchi I Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571 [No Abstract] [Full Text] [Related]
7. Effect of coadministration of verapamil and quinidine on serum digoxin concentration. Doering W Eur J Clin Pharmacol; 1983; 25(4):517-21. PubMed ID: 6653647 [TBL] [Abstract][Full Text] [Related]
8. The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levels. Weeks CE; Conard GJ; Kvam DC; Fox JM; Chang SF; Paone RP; Lewis GP J Clin Pharmacol; 1986 Jan; 26(1):27-31. PubMed ID: 3950050 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of verapamil and isradipine on steady-state digoxin kinetics. Rodin SM; Johnson BF; Wilson J; Ritchie P; Johnson J Clin Pharmacol Ther; 1988 Jun; 43(6):668-72. PubMed ID: 2967742 [TBL] [Abstract][Full Text] [Related]
10. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations. Bauer LA; Horn JR; Pettit H Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820 [TBL] [Abstract][Full Text] [Related]
11. Current status of cardiac glycoside drug interactions. Hooymans PM; Merkus FW Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751 [TBL] [Abstract][Full Text] [Related]
12. Influence of verapamil on the inotropism and pharmacokinetics of digoxin. Pedersen KE; Thayssen P; Klitgaard NA; Christiansen BD; Nielsen-Kudsk F Eur J Clin Pharmacol; 1983; 25(2):199-206. PubMed ID: 6628501 [TBL] [Abstract][Full Text] [Related]
14. The effect of quinidine on digoxin kinetics in cardiac patients. Pedersen KE; Hastrup J; Hvidt S Acta Med Scand; 1980; 207(4):291-5. PubMed ID: 7386224 [TBL] [Abstract][Full Text] [Related]
15. A model for the prediction of digoxin-drug interactions at the renal tubular cell level. Woodland C; Ito S; Koren G Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the pharmacodynamic and pharmacokinetic interaction between calcium antagonists and digoxin. De Vito JM; Friedman B Pharmacotherapy; 1986; 6(2):73-82. PubMed ID: 3520498 [TBL] [Abstract][Full Text] [Related]
18. Effect of nifedipine on digoxin kinetics in healthy subjects. Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Kjaer K; Nielsen-Kudsk F Clin Pharmacol Ther; 1982 Nov; 32(5):562-5. PubMed ID: 7127997 [TBL] [Abstract][Full Text] [Related]
20. The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics. Johnson BF; Wilson J; Marwaha R; Hoch K; Johnson J Clin Pharmacol Ther; 1987 Jul; 42(1):66-71. PubMed ID: 2954736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]